The estimated Net Worth of Christoph H Westphal is at least $14 millió dollars as of 8 November 2016. Christoph Westphal owns over 7,000 units of Verastem Inc stock worth over $11,035,130 and over the last 20 years Christoph sold VSTM stock worth over $2,955,832.
Christoph has made over 82 trades of the Verastem Inc stock since 2004, according to the Form 4 filled with the SEC. Most recently Christoph sold 3,212,861 units of VSTM stock worth $2,955,832 on 16 October 2018.
The largest trade Christoph's ever made was selling 3,212,861 units of Verastem Inc stock on 16 October 2018 worth over $2,955,832. On average, Christoph trades about 65,191 units every 49 days since 2004. As of 8 November 2016 Christoph still owns at least 3,941,118 units of Verastem Inc stock.
You can see the complete history of Christoph Westphal stock trades at the bottom of the page.
Christoph's mailing address filed with the SEC is C/O VERASTEM, INC.,, 117 KENDRICK STREET, SUITE 500, NEEDHAM, MA, 02494.
Over the last 13 years, insiders at Verastem Inc have traded over $5,883,823 worth of Verastem Inc stock and bought 3,873,819 units worth $28,318,633 . The most active insiders traders include Capital Management, L.P.Ra ..., Christoph H Westphal és Ansbert Gadicke. On average, Verastem Inc executives and independent directors trade stock every 28 days with the average trade being worth of $112,479. The most recent stock trade was executed by Dan Paterson on 5 August 2024, trading 3,245 units of VSTM stock currently worth $7,009.
verastem, inc. (nasdaq: vstm) is a biopharmaceutical company focused on discovering and developing novel drugs that selectively target cancer stem cells. cancer stem cells are an underlying cause of tumor recurrence and metastasis. verastem is translating breakthrough discoveries in cancer stem cell research into new medicines for the treatment of major cancers such as breast cancer. for more information, please visit www.versatem.com
Verastem Inc executives and other stock owners filed with the SEC include: